Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers
Keywords: clinical trial; COPD; EETs; endothelial function; smokers; soluble epoxide hydrolase inhibitor; CYP; cytochrome P450; DHET; dihydroxyepoxyeicosatrienoic acid; EC50; half maximal effective concentration; EDHF; endothelium-derived hyperpolarizing factor; EE